AnaptysBio, Inc. (ANAB) Tops Q3 EPS by 56c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q3 EPS of ($1.14), $0.56 better than the analyst estimate of ($1.70). Revenue for the quarter came in at $30.02 million versus the consensus estimate of $6.92 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• Active options: NVDA TSLA AAPL INTC MU SPCX AMZN GOOGL AMD
• Pakistan, Iran Explore Path Towards New Talks With US In A China-initiated Push, Sources Say - Reuters